Develops nerve grafts for peripheral nerve injuries.
Jun 2026Revenue $251M/yrExpenses $264M/yr
No trend
Figures by year
When will Axogen be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $251M and expenses $264M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $225M | $233M | −$7.85M |
| Dec 2024 | $187M | $191M | −$3.29M |
| Dec 2023 | $159M | $180M | −$21.5M |
| Dec 2022 | $139M | $168M | −$29.7M |
| Dec 2021 | $127M | $153M | −$25.4M |
| Dec 2020 | $112M | $135M | −$23.2M |
| Dec 2019 | $107M | $138M | −$31.4M |
| Dec 2018 | $83.9M | $104M | −$20.5M |
| Dec 2017 | $60.4M | $68.4M | −$7.95M |
| Dec 2016 | $41.1M | $49.2M | −$8.13M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.